| Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study S Blach, S Zeuzem, M Manns, I Altraif, AS Duberg, DH Muljono, I Waked, ... The lancet Gastroenterology & hepatology 2 (3), 161-176, 2017 | 2179 | 2017 |
| High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load TC Tseng, CJ Liu, HC Yang, TH Su, CC Wang, CL Chen, SFT Kuo, ... Gastroenterology 142 (5), 1140-1149. e3, 2012 | 692 | 2012 |
| Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study S Blach, NA Terrault, F Tacke, I Gamkrelidze, A Craxi, J Tanaka, I Waked, ... The Lancet Gastroenterology & Hepatology 7 (5), 396-415, 2022 | 482 | 2022 |
| Serum hepatitis B surface antigen levels help predict disease progression in patients with low hepatitis B virus loads TC Tseng, CJ Liu, HC Yang, TH Su, CC Wang, CL Chen, CA Hsu, ... Hepatology 57 (2), 441-450, 2013 | 328 | 2013 |
| Efficacy of maternal tenofovir disoproxil fumarate in interrupting mother‐to‐infant transmission of hepatitis B virus HL Chen, CN Lee, CH Chang, YH Ni, MK Shyu, SM Chen, JJ Hu, HH Lin, ... Hepatology 62 (2), 375-386, 2015 | 308 | 2015 |
| Serum hepatitis B surface antigen levels predict surface antigen loss in hepatitis B e antigen seroconverters TC Tseng, CJ Liu, TH Su, CC Wang, CL Chen, PJ Chen, DS Chen, ... Gastroenterology 141 (2), 517-525. e2, 2011 | 255 | 2011 |
| Four‐year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients TH Su, TH Hu, CY Chen, YH Huang, WL Chuang, CC Lin, CC Wang, ... Liver International 36 (12), 1755-1764, 2016 | 234 | 2016 |
| Hepatitis B virus–specific T cells associate with viral control upon nucleos (t) ide-analogue therapy discontinuation L Rivino, N Le Bert, US Gill, K Kunasegaran, Y Cheng, DZM Tan, E Becht, ... The Journal of clinical investigation 128 (2), 668-681, 2018 | 214 | 2018 |
| Determinants of spontaneous surface antigen loss in hepatitis B e antigen–negative patients with a low viral load TC Tseng, CJ Liu, HC Yang, TH Su, CC Wang, CL Chen, S Fang‐Tzu Kuo, ... Hepatology 55 (1), 68-76, 2012 | 207 | 2012 |
| Higher proportion of viral basal core promoter mutant increases the risk of liver cirrhosis in hepatitis B carriers TC Tseng, CJ Liu, HC Yang, CL Chen, WT Yang, CS Tsai, SFT Kuo, ... Gut 64 (2), 292-302, 2015 | 146 | 2015 |
| Off-therapy response after nucleos (t) ide analogue withdrawal in patients with chronic hepatitis B: an international, multicenter, multiethnic cohort (RETRACT-B study) G Hirode, HSJ Choi, CH Chen, TH Su, WK Seto, S Van Hees, ... Gastroenterology 162 (3), 757-771. e4, 2022 | 145 | 2022 |
| Serum hepatitis B surface antigen concentration correlates with HBV DNA level in patients with chronic hepatitis B TH Su, CS Hsu, CL Chen, CH Liu, YW Huang, TC Tseng, CJ Liu, PJ Chen, ... Antiviral therapy 15 (8), 1133-1139, 2010 | 135 | 2010 |
| High level of hepatitis B core–related antigen associated with increased risk of hepatocellular carcinoma in patients with chronic HBV infection of intermediate viral load TC Tseng, CJ Liu, CY Hsu, CM Hong, TH Su, WT Yang, CL Chen, ... Gastroenterology 157 (6), 1518-1529. e3, 2019 | 129 | 2019 |
| Pegylated interferon-α2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 1 receiving hemodialysis: a randomized trial CH Liu, CF Huang, CJ Liu, CY Dai, CC Liang, JF Huang, PH Hung, ... Annals of internal medicine 159 (11), 729-738, 2013 | 117 | 2013 |
| Molecular mechanism and treatment of viral hepatitis-related liver fibrosis TH Su, JH Kao, CJ Liu International journal of molecular sciences 15 (6), 10578-10604, 2014 | 96 | 2014 |
| Sorafenib and its derivative SC-1 exhibit antifibrotic effects through signal transducer and activator of transcription 3 inhibition TH Su, CW Shiau, P Jao, CH Liu, CJ Liu, WT Tai, YM Jeng, HC Yang, ... Proceedings of the National Academy of Sciences 112 (23), 7243-7248, 2015 | 88 | 2015 |
| Comparison of Abbott RealTime HCV Genotype II with Versant line probe assay 2.0 for hepatitis C virus genotyping CH Liu, CC Liang, CJ Liu, CL Lin, TH Su, HC Yang, PJ Chen, DS Chen, ... Journal of clinical microbiology 53 (5), 1754-1757, 2015 | 83 | 2015 |
| Real-world effectiveness from the Asia Pacific Rim Liver Consortium for HBV risk score for the prediction of hepatocellular carcinoma in chronic hepatitis B patients treated … HI Yang, ML Yeh, GL Wong, CY Peng, CH Chen, HN Trinh, KS Cheung, ... The Journal of infectious diseases 221 (3), 389-399, 2020 | 82 | 2020 |
| Clinical manifestations and outcomes of patients with sarcomatoid hepatocellular carcinoma SH Liao, TH Su, YM Jeng, PC Liang, DS Chen, CH Chen, JH Kao Hepatology 69 (1), 209-221, 2019 | 81 | 2019 |
| Distinct relapse rates and risk predictors after discontinuing tenofovir and entecavir therapy TH Su, HC Yang, TC Tseng, JM Liou, CH Liu, CL Chen, PJ Chen, ... The Journal of infectious diseases 217 (8), 1193-1201, 2018 | 80 | 2018 |
JH KaoNational Taiwan UniversityZweryfikowany adres z ntu.edu.tw